Jpmorgan Chase & CO Biovie Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.4 - $0.56 $4,092 - $5,728
10,230 Added 418.92%
12,672 $5,000
Q1 2024

May 10, 2024
BUY
$0.53 - $1.89 $148 - $529
280 Added 12.95%
2,442 $1,000
Q4 2023

Feb 12, 2024
BUY
$1.22 - $5.24 $12 - $52
10 Added 0.46%
2,162 $2,000
Q3 2023

Nov 14, 2023
SELL
$2.75 - $5.17 $1,358 - $2,553
-494 Reduced 18.67%
2,152 $7,000
Q2 2023

Aug 11, 2023
BUY
$4.09 - $8.29 $10,822 - $21,935
2,646 New
2,646 $11,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $97.1M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email